Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.

According to APO Research, The global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) include Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee and Fluxion, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), also provides the revenue of main regions and countries. Of the upcoming market potential for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) revenue, projected growth trends, production technology, application and end-user industry.

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) segment by Company

Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) segment by Type

CellSearch
Others
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) segment by Application

Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)revenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CellSearch
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Other Cancers Diagnosis and Treatment
1.4 Global Market Growth Prospects
1.5 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Growth Trends by Region
1.5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2019-2024)
1.5.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Dynamics
2.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Trends
2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Drivers
2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Opportunities and Challenges
2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Restraints
3 Competitive Landscape by Company
3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Company (2019-2024)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Company Head office and Area Served
3.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Company, Product Type & Application
3.5 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market CR5 and HHI
3.6.2 Global Top 5 and 10 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Market Share by Revenue in 2023
3.6.3 2023 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Tier 1, Tier 2, and Tier 3
4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Type
4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2019-2030)
4.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2019-2030)
5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Application
5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2019-2030)
5.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2019-2030)
6 Company Profiles
6.1 Janssen
6.1.1 Janssen Comapny Information
6.1.2 Janssen Business Overview
6.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.1.5 Janssen Recent Developments
6.2 Qiagen
6.2.1 Qiagen Comapny Information
6.2.2 Qiagen Business Overview
6.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.2.5 Qiagen Recent Developments
6.3 Advanced Cell Diagnostics
6.3.1 Advanced Cell Diagnostics Comapny Information
6.3.2 Advanced Cell Diagnostics Business Overview
6.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.3.5 Advanced Cell Diagnostics Recent Developments
6.4 ApoCell
6.4.1 ApoCell Comapny Information
6.4.2 ApoCell Business Overview
6.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.4.5 ApoCell Recent Developments
6.5 Biofluidica
6.5.1 Biofluidica Comapny Information
6.5.2 Biofluidica Business Overview
6.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.5.5 Biofluidica Recent Developments
6.6 Clearbridge Biomedics
6.6.1 Clearbridge Biomedics Comapny Information
6.6.2 Clearbridge Biomedics Business Overview
6.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.6.5 Clearbridge Biomedics Recent Developments
6.7 CytoTrack
6.7.1 CytoTrack Comapny Information
6.7.2 CytoTrack Business Overview
6.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.7.5 CytoTrack Recent Developments
6.8 Celsee
6.8.1 Celsee Comapny Information
6.8.2 Celsee Business Overview
6.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.8.5 Celsee Recent Developments
6.9 Fluxion
6.9.1 Fluxion Comapny Information
6.9.2 Fluxion Business Overview
6.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.9.5 Fluxion Recent Developments
6.10 Gilupi
6.10.1 Gilupi Comapny Information
6.10.2 Gilupi Business Overview
6.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.10.5 Gilupi Recent Developments
6.11 Cynvenio
6.11.1 Cynvenio Comapny Information
6.11.2 Cynvenio Business Overview
6.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.11.4 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.11.5 Cynvenio Recent Developments
6.12 On-chip
6.12.1 On-chip Comapny Information
6.12.2 On-chip Business Overview
6.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.12.4 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.12.5 On-chip Recent Developments
6.13 YZY Bio
6.13.1 YZY Bio Comapny Information
6.13.2 YZY Bio Business Overview
6.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.13.4 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.13.5 YZY Bio Recent Developments
6.14 BioView
6.14.1 BioView Comapny Information
6.14.2 BioView Business Overview
6.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.14.4 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.14.5 BioView Recent Developments
6.15 Fluidigm
6.15.1 Fluidigm Comapny Information
6.15.2 Fluidigm Business Overview
6.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.15.4 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.15.5 Fluidigm Recent Developments
6.16 Ikonisys
6.16.1 Ikonisys Comapny Information
6.16.2 Ikonisys Business Overview
6.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.16.4 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.16.5 Ikonisys Recent Developments
6.17 AdnaGen
6.17.1 AdnaGen Comapny Information
6.17.2 AdnaGen Business Overview
6.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.17.4 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.17.5 AdnaGen Recent Developments
6.18 IVDiagnostics
6.18.1 IVDiagnostics Comapny Information
6.18.2 IVDiagnostics Business Overview
6.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.18.4 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.18.5 IVDiagnostics Recent Developments
6.19 Miltenyi Biotec
6.19.1 Miltenyi Biotec Comapny Information
6.19.2 Miltenyi Biotec Business Overview
6.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.19.4 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.19.5 Miltenyi Biotec Recent Developments
6.20 ScreenCell
6.20.1 ScreenCell Comapny Information
6.20.2 ScreenCell Business Overview
6.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.20.4 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.20.5 ScreenCell Recent Developments
6.21 Silicon Biosystems
6.21.1 Silicon Biosystems Comapny Information
6.21.2 Silicon Biosystems Business Overview
6.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Gross Margin (US$ Million) & (2019-2024)
6.21.4 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
6.21.5 Silicon Biosystems Recent Developments
7 North America
7.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2019-2030)
7.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
7.2.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2019-2024)
7.2.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2025-2030)
7.2.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2019-2030)
7.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
7.3.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2019-2024)
7.3.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2025-2030)
7.3.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2019-2030)
7.4 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country
7.4.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019-2024)
7.4.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2025-2030)
7.4.4 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 Europe
8.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2019-2030)
8.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
8.2.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2019-2024)
8.2.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2025-2030)
8.2.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2019-2030)
8.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
8.3.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2019-2024)
8.3.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2025-2030)
8.3.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2019-2030)
8.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country
8.4.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019-2024)
8.4.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2025-2030)
8.4.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2019-2030)
9.2 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
9.2.1 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2019-2024)
9.2.2 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2025-2030)
9.2.3 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2019-2030)
9.3 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
9.3.1 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2019-2024)
9.3.2 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2025-2030)
9.3.3 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2019-2030)
10 Asia
10.1 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2019-2030)
10.2 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
10.2.1 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2019-2024)
10.2.2 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2025-2030)
10.2.3 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2019-2030)
10.3 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
10.3.1 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2019-2024)
10.3.2 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2025-2030)
10.3.3 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2019-2030)
10.4 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country
10.4.1 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019-2024)
10.4.3 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2025-2030)
10.4.4 Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2019-2030)
11.2 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
11.2.1 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2019-2024)
11.2.2 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2025-2030)
11.2.3 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2019-2030)
11.3 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
11.3.1 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2019-2024)
11.3.2 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2025-2030)
11.3.3 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2019-2030)
11.4 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country
11.4.1 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2019-2024)
11.4.3 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2025-2030)
11.4.4 MEALA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings